Genentech's Avastin meets breast cancer study goal
681279
Genentech Inc said on Tuesday its cancer drug, Avastin, met the primary goal of prolonging progression-free survival when combined with chemotherapy in a breast cancer study, sending its shares up more than 3 percent.
249246
Genentech and Biogen Idec's drug shows positive results against multiple sclerosis.
606459
Genentech said that approval of its colon cancer drug Avastin as a treatment for breast cancer would be delayed by at least a year.
393500
FRIDAY, Dec. 15 (HealthDay News) -- U.S. researchers have developed two genomic tests to help doctors better predict how breast cancer patients will respond to hormonal therapy or chemotherapy.
320785
The results of studies released today show a new blood test holds promise for improving the treatment of advanced breast cancer.
194383
Biotechnology company Genentech Inc  said on Monday its fourth-quarter profit rose 6.4 percent, but sales of several drugs, including blockbuster cancer drug Avastin, fell short of investor expectations, sending the company's shares lower.
435359
Description: Researchers meeting in San Antonio are reporting promising results about a new genetic test that can predict which breast cancer patients will benefit from chemotherapy.
56445
WEDNESDAY, Jan. 16 (HealthDay News) -- A new genetic test that helps assess the risk of tumor recurrence and long-term survival for patients with relatively high-risk breast cancer has been approved by the U.S. Food and Drug Administration.
523916
TUESDAY, Feb. 20 (HealthDay News) -- The cancer drug Avastin (bevacizumab) appears able to slow the growth of the most common and deadly form of brain cancer -- gliomas -- and extend patient survival, according to a pilot study conducted at Duke University Medical Center in Durham, N.C.
36253
The drug Avastin helped stem the progression of advanced kidney cancer better than standard therapy alone, according to a study released at the American Society of Clinical Oncology's annual meeting on Saturday.
688355
Genentech Inc.  said on Wednesday that second-quarter profit rose 41 percent, fueled by growth from cancer drugs Rituxan and Avastin.
257114
Genentech Inc. (DNA.N: Quote, Profile, Research) on Wednesday said third-quarter earnings rose 50 percent, spurred by growth in new colon cancer treatment Avastin and strong sales of its
439386
The FDA asks for more data about Avastin, which could be used to treat various cancers.
229876
New findings add to the evidence that genetic tests can help predict whether breast cancer will recur, giving valuable guidance to doctors and patients about whether potentially toxic chemotherapy
240917
Genentech Inc.  on Wednesday said second-quarter profit rose 41 percent, fueled by growth from key cancer drugs Avastin and Rituxan, and it boosted its full-year profit forecast.
704815
A new breast cancer drug is significantly better at preventing the spread and return of the disease than the current treatment, according to a new study in the Lancet medical journal.
603105
THURSDAY, Dec. 14 (HealthDay News) -- Adding the drug Avastin to traditional chemotherapy for patients with advanced lung cancer prolonged survival by several months, a new study found.